References
- Latagliata R, Petti MC, Fenu S, . Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem. Blood 2002;99: 822–824.
- Betancourt-Garcia RD, Castro J, Fernandez AC, . Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature. P R Health Sci J 2009;28:146–150.
- Ades L, Sanz MA, Chevret S, . Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood 2008;111:1078–1084.
- Arcila M, Lau C, Nafa K, . Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping. J Mol Diagn 2011;13:64–73.
- Dash A, Gilliland DG. Molecular genetics of acute myeloid leukaemia. Best Pract Res Clin Haematol 2001;14:49–64.
- Varmus HE. The molecular genetics of cellular oncogenes. Annu Rev Genet 1984;18:553–612.
- Needleman SW, Kraus MH, Srivastava SK, . High frequency of N-ras activation in acute myelogenous leukemia. Blood 1986;67: 753–757.
- Bos JL, Toksoz D, Marshall CJ, . Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature 1985;315:726–730.
- Bos JL, Verlaan-de Vries M, van der Eb AJ, . Mutations in N-ras predominate in acute myeloid leukemia. Blood 1987;69:1237–1241.
- Bacher U, Haferlach T, Schoch C, . Implications of NRAS mutations in AML: a study of 2502 patients. Blood 2006;107: 3847–3853.
- Janssen JW, Steenvoorden AC, Lyons J, . RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc Natl Acad Sci USA 1987;84:9228–9232.
- Hirai H, Kobayashi Y, Mano H, . A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 1987;327:430–432.
- Ricci C, Fermo E, Corti S, . RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant. Clin Cancer Res 2010;16:2246–2256.
- Swerdlow SH, Campo, E., Harris NL, ., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008.
- Pedersen-Bjergaard J, Christiansen DH, Desta F, . Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2006;20:1943–1949.